The North America Biosurgery Market is expected to witness market growth of 6.4% CAGR during the forecast period (2019-2025).
Biosurgery is a biotherapy involving the introduction of life, disinfected maggots into the non-healing skin and soft tissue wound of a human or animal. It helps to clean out the necrotic tissue within a wound and disinfection. It was long believed that the debridement was selective on necrotic tissue, but new literature has questioned that belief. Fibrin and collagen sealant, hemostats, soft tissue attachments, adhesion barriers, and bone morphogenetic proteins are among the prevalent biosurgery products. The extensive investments by governments have improved healthcare facilities; this is expected to significantly expand the market. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.
The scenario of the biosurgery market across American countries is influenced by the increased sport-related injuries and spinal injuries. Certain factors driving the market growth are the rise in per capita healthcare spending, the increase in the number of surgeries due to an increase in the obese population along with lifestyle disorders. Despite the numerous benefits, market growth is still hampered by factors such as high costs, and consumers ' growing preference for minimally invasive surgery as opposed to conventional surgery.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
By Product
By Country
Companies Profiled
Unique Offerings from the Publisher
Biosurgery is a biotherapy involving the introduction of life, disinfected maggots into the non-healing skin and soft tissue wound of a human or animal. It helps to clean out the necrotic tissue within a wound and disinfection. It was long believed that the debridement was selective on necrotic tissue, but new literature has questioned that belief. Fibrin and collagen sealant, hemostats, soft tissue attachments, adhesion barriers, and bone morphogenetic proteins are among the prevalent biosurgery products. The extensive investments by governments have improved healthcare facilities; this is expected to significantly expand the market. Biosurgery has provided a new potential in regenerative healing with the right combination of synthetics and biologics. The introduction of multi-use products arising from intensive research from major life sciences players has paved the way for lucrative prospects in the biosurgery market. Healthcare players are actively focused on boosting the new prospect of the market by developing novel biomaterials.
The scenario of the biosurgery market across American countries is influenced by the increased sport-related injuries and spinal injuries. Certain factors driving the market growth are the rise in per capita healthcare spending, the increase in the number of surgeries due to an increase in the obese population along with lifestyle disorders. Despite the numerous benefits, market growth is still hampered by factors such as high costs, and consumers ' growing preference for minimally invasive surgery as opposed to conventional surgery.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
By Product
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Biosurgery Market by Application
Chapter 5. North America Biosurgery Market by Product
Chapter 6. North America Biosurgery Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
Methodology
LOADING...
